Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by RichyRich$on Feb 14, 2014 8:42pm
216 Views
Post# 22212994

Never Fall in Love With a Stock (Cardinal Rule of Trading)

Never Fall in Love With a Stock (Cardinal Rule of Trading)A little advice in line with Valentines Day... Never Fall in Love With a Stock (one of the cardinal rules of trading).  Shamool, I'm thinking the same thing.  SVA was $.12 just last Monday and now more than doubled in just 5 days without and efficacy results out!  It wouldn't take much to bring it down back to $.15 if a few large long commercial investors decide they want out now to pursue other opportunities.  Also, keep in mind, the Health Care Sector ETF has been back to rallying in the U.S., this is helping out all medical companies, so possilby sold too soon.  I felt very volunerable with this stock, because being a Type 1 Diabetic it's worth $100 to me, but that's falling in love with a stock.  I even found myself not wanting to research the competition.  There is research going on where no pouch is required, rather genetic engineering to reactivate a type 1 diabetics original insulin beta cells.  A type 1 diabetic would prefer such an approach and not need to have a pouch inserted under the skin.  However, that research could me many years out.  So I still believe within the next 5 to 10 years, this is the solution.  I'm taking a bit of a gamble hear and sold at $.23.  I will buy it back if it pulls back.  If not, that's the life of trading.  Last year I bought Air Canada at $2.00 and sold at $2.30, only to see it sky rocket to $10.00 by the end of the year!  You simply deal with it.  I sold Sernova $.23 today to buy JC Penney.  It used to be $77 in 2007 and $44 in 2012 and hit rock bottom a week ago at $4.90.  I believe it'll be back to $20.00 in 12 months as a turnaround and profits are underway.  So there's many ways to make money in the stock market.  I felt this was a good strategy because JC Penney has a 50% Short Float and is now Short Squeezing, so there's a chance I can make a descent profit there and buy back Sernova at $.15.  Or both Sernova and JC Penney increase at par.  No one want's Sernova to succeed more than type 1 diabetics.  But I was becoming blind to research only the postive and not the competition.  May the Best Cure Win now!  
Bullboard Posts